NPD1-mediated stereoselective regulation of BIRC3 expression through cREL is decisive for neural cell survival

Cell Death and Differentiation

Volumn 22, Issue 8, 2015, Pages 1363-1377

  Calandria, J M ^a   Asatryan, A ^a   Balaszczuk, V ^a   Knott, E J ^a   Jun, B K ^a   Mukherjee, P K ^a   Belayev, L ^a   Bazan, N G ^a  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOCOSAHEXAENOIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NEUROPROTECTIN D1; NEUROPROTECTIVE AGENT; PROTEIN BIRC3; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR CREL; TRANSCRIPTION FACTOR RELB; TUMOR NECROSIS FACTOR RECEPTOR 1; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG; BIRC3 PROTEIN, HUMAN; INHIBITOR OF APOPTOSIS PROTEIN; PROTECTIN D1; TRANSCRIPTION FACTOR REL; UBIQUITIN PROTEIN LIGASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN ISCHEMIA; BRAIN NERVE CELL; CELL SURVIVAL; CONTROLLED STUDY; GENE CLUSTER; GENETIC TRANSCRIPTION; HOMEOSTASIS; HUMAN; HUMAN CELL; MALE; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; OXIDATIVE STRESS; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; RAT; RETINA NERVE CELL; SIGNAL TRANSDUCTION; STEREOSPECIFICITY; CELL CULTURE; DRUG EFFECTS; GENETICS; METABOLISM;

CELL SURVIVAL; CELLS, CULTURED; DOCOSAHEXAENOIC ACIDS; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; OXIDATIVE STRESS; PROTO-ONCOGENE PROTEINS C-REL; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR RELB; UBIQUITIN-PROTEIN LIGASES;

EID: 84935721447     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/cdd.2014.233     Document Type: Article

References (43)

1. Han J, Zhong CQ, Zhang DW. Programmed necrosis: backup to and competitor with apoptosis in the immune system. Nat Immunol 2011; 12: 1143-1149.
2. Gyrd-Hansen M, Meier P. IAPs: from caspase inhibitors to modulators of NF-?B, inflammation and cancer. Nat Rev Cancer 2010; 10: 561-574.
3. Mace PD, Shirley S, Day CL. Assembling the building blocks: structure and function of inhibitor of apoptosis proteins. Cell Death Differ 2010; 17: 46-53.
4. Feng S, Yang Y, Mei Y, Ma L, Zhu DE, Hoti N et al. Cleavage of RIP3 inactivates its caspase-independent apoptosis pathway by removal of kinase domain. Cell Signal 2007; 19: 2056-2067.
5. Huang JF, Shang L, Zhang MQ, Wang H, Chen D, Tong JB et al. Differential neuronal expression of receptor interacting protein 3 in rat retina: involvement in ischemic stress response. BMC Neurosci 2013; 14: 16.
6. Nicotera P, Lipton SA. Excitotoxins in neuronal apoptosis and necrosis. J Cereb Blood Flow Metab 1999; 19: 583-591.
7. Rosenbaum DM, Degterev A, David J, Rosenbaum PS, Roth S, Grotta JC et al. Necroptosis, a novel form of caspase-independent cell death, contributes to neuronal damage in a retinal ischemia-reperfusion injury model. J Neurosci Res 2010; 88: 1569-1576.
8. Long JS, Ryan KM. New frontiers in promoting tumour cell death: targeting apoptosis, necroptosis and autophagy. Oncogene 2012; 31: 5054-5060.
9. Bazan NG, Molina MF, Gordon WC. Docosahexaenoic acid signalolipidomics in nutrition: significance in aging, neuroinflammation, macular degeneration, Alzheimer's, and other neurodegenerative diseases. Annu Rev Nutr 2011; 31: 321-351.
10. Calandria JM, Marcheselli VL, Mukherjee PK, Uddin J, Winkler JW, Petasis NA et al. Selective survival rescue in 15-lipoxygenase-1-deficient retinal pigment epithelial cells by the novel docosahexaenoic acid-derived mediator, neuroprotectin D1. J Biol Chem 2009; 284: 17877-17882.
11. Marcheselli VL, Mukherjee PK, Arita M, Hong S, Antony R, Sheets K et al. Neuroprotectin D1/protectin D1 stereoselective and specific binding with human retinal pigment epithelial cells and neutrophils. Prostaglandins Leukot Essent Fatty Acids 2010; 82: 27-34.
12. Mukherjee PK, Marcheselli VL, Serhan CN, Bazan NG. Neuroprotectin D1: a docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress. Proc Natl Acad Sci USA 2004; 101: 8491-8496.
13. Mukherjee PK, Marcheselli VL, Barreiro S, Hu J, Bok D, Bazan NG. Neurotrophins enhance retinal pigment epithelial cell survival through neuroprotectin D1 signaling. Proc Natl Acad Sci USA 2007; 104: 13152-13157.
14. Calandria JM, Mukherjee PK, de Rivero Vaccari JC, Zhu M, Petasis NA, Bazan NG. Ataxin-1 poly(Q)-induced proteotoxic stress and apoptosis are attenuated in neural cells by docosahexaenoic acid-derived neuroprotectin D1. J Biol Chem 2012; 287: 23726-23739.
15. Dunn KC, Aotaki-Keen AE, Putkey FR, Hjelmeland LM. ARPE-19, a human retinal pigment epithelial cell line with differentiated properties. Exp Eye Res 1996; 62: 155-169.
16. Strauss O. The retinal pigment epithelium in visual function. Physiol Rev 2005; 85: 845-881.
17. Sparrow JR, Hicks D, Hamel CP. The retinal pigment epithelium in health and disease. Curr Mol Med 2010; 10: 802-823.
18. Lukiw WJ, Cui JG, Marcheselli VL, Bodker M, Botkjaer A, Gotlinger K et al. A role for docosahexaenoic acid-derived neuroprotectin D1 in neural cell survival and Alzheimer disease. J Clin Invest 2005; 115: 2774-2783.
19. Zhao Y, Calon F, Julien C, Winkler JW, Petasis NA, Lukiw WJ et al. Docosahexaenoic acidderived neuroprotectin D1 induces neuronal survival via secretase-and PPAR?-mediated mechanisms in Alzheimer's disease models. PLoS ONE 2011; 6: e15816.
20. Serhan CN, Krishnamoorthy S, Recchiuti A, Chiang N. Novel anti-inflammatory-proresolving mediators and their receptors. Curr Top Med Chem 2011; 11: 629-647.
21. Serhan CN, Yang R, Martinod K, Kasuga K, Pillai PS, Porter TF et al. Maresins: novel macrophage mediators with potent antiinflammatory and proresolving actions. J Exp Med 2009; 206: 15-23.
22. Viatour P1, Merville MP, Bours V, Chariot A. Phosphorylation of NF-kappaB and IkappaB proteins: implications in cancer and inflammation. Trends Biochem Sci 2005; 30: 43-52.
23. Hong SY, Yoon WH, Park JH, Kang SG, Ahn JH, Lee TH et al. Involvement of two NF-kappa B binding elements in tumor necrosis factor alpha-, CD40-, and epstein-barr virus latent membrane protein 1-mediated induction of the cellular inhibitor of apoptosis protein 2 gene. J Biol Chem 2000; 275: 18022-18028.
24. Eckelman BP, Salvesen GS. The human anti-apoptotic proteins cIAP1 and cIAP2 bind but do not inhibit caspases. J Biol Chem 2006; 281: 3254-3260.
25. Xiao G, Fu J. NF-B and cancer: a paradigm of Yin-Yang. Am J Cancer Res 2011; 1: 192-221.
26. Hoffmann A, Levchenko A, Scott ML, Baltimore D. The IB-NF-B signaling module: temporal control and selective gene activation. Science 2002; 298: 1241-1245.
27. Nelson DE, Ihekwaba AE, Elliott M, Johnson JR, Gibney CA, Foreman BE et al. Oscillations in NF-B signaling control the dynamics of gene expression. Science 2004; 306: 704-708.
28. Lipniacki T, Paszek P, Brasier AR, Luxon B, Kimmel M. Mathematical model of NFkappaB regulatory module. J Theor Biol 2004; 228: 195-215.
29. Sung MH, Salvatore L, De Lorenzi R, Indrawan A, Pasparakis M, Hager GL et al. Sustained oscillations of NF-kappaB produce distinct genome scanning and gene expression profiles. PLoS ONE 2009; 4: e7163.
30. Feoktistova M, Geserick P, Kellert B, Dimitrova DP, Langlais C, Hupe M et al. cIAPs block Ripoptosome formation, a RIP1/caspase-8 containing intracellular cell death complex differentially regulated by cFLIP isoforms. Mol Cell 2011; 43: 449-463.
31. He S, Wang L, Miao L, Wang T, Du F, Zhao L et al. Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha. Cell 2009; 137: 11001111.
32. Nicotera P, Melino G. Regulation of the apoptosis-necrosis switch. Oncogene 2004; 23: 2757-2765.
33. Marcheselli VL, Hong S, Lukiw WJ, Tian XH, Gronert K, Musto A et al. Novel docosanoids inhibit brain ischemia-reperfusion-mediated leukocyte infiltration and pro-inflammatory gene expression. J Biol Chem 2003; 278: 43807-43817.
34. Belayev L, Khoutorova L, Atkins KD, Eady TN, Hong S, Lu Y et al. Docosahexaenoic acid therapy of experimental ischemic stroke. Transl Stroke Res 2011; 2: 33-41.
35. PizziM, Sarnico I, Lanzillotta A, Battistin L, Spano PF. Post-ischemic brain damage: NF-Bdimer heterogeneity as a molecular determinant of neuron vulnerability. FEBS J 2009; 276: 27-35.
36. Valerio A, Dossena M, Bertolotti P, Boroni F, Sarnico I, Faraco G et al. Leptin is induced in the ischemic cerebral cortex and exerts neuroprotection through NF-kappaB/c-Reldependent transcription. Stroke 2009; 40: 610-617.
37. Jiang C, Xuan Z, Zhao F, Zhang MQ. TRED: a transcriptional regulatory element database, new entries and other development. Nucleic Acids Res 2007; 35: D137-D140.
38. Heinemeyer T, Wingender E, Reuter I, Hermjakob H, Kel AE, Kel OV et al. Databases on transcriptional regulation: TRANSFAC, TRRD and COMPEL. Nucleic Acids Res 1998; 26: 362-367.
39. Tsunoda T, Takagi T. Estimating transcription factor bindability on DNA. Bioinformatics 1999; 15: 622-630.
40. Bren GD, Solan NJ, Miyoshi H, Pennington KN, Pobst LJ, Paya CV et al. Transcription of the RelB gene is regulated by NF-kappaB. Oncogene 2001; 20: 7722-7733.
41. Ueberla K, Lu Y, Chung E, Haseltine WA. The NF-kappa B p65 promoter. J Acquir Immune Defic Syndr 1993; 6: 227-230.
42. Viswanathan M, Yu M, Mendoza L, Yunis JJ. Cloning and transcription factor-binding sites of the human c-rel proto-oncogene promoter. Gene 1996; 170: 271-276.
43. Tae G, Scatena M, Stayton PS, Hoffman AS. PEG-cross-linked heparin is an affinity hydrogel for sustained release of vascular endothelial growth factor. J Biomater Sci Polym Ed 2006; 17: 187-197.